Navigation Links
ISBT 128 Labeling Implementation Date Looms for Blood Centers
Date:3/26/2008

stitutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com .

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.


'/>"/>
SOURCE Mediware Information Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
2. IOM workshop on less confusing drug labeling, Oct. 12
3. GSK Revises US Labeling for Avandia(R)
4. FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, Enough Is Enough
5. Truthful Labeling Coalition Welcomes Perdue Farms
6. Consumer Group Criticizes NYC Board of Health Over Menu Labeling Bill
7. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
8. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
9. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
10. AHIMA Signs Contract With CMS for ICD-10 Implementation Assessment and Training
11. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... comprehensive information on the therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive ... new targets and MOAs to produce first-in-class and best-in-class products. Complete report on ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... sponsor, with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s ... organization that is actively addressing Line of Duty Deaths (LODD) and the high ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... testing regulations imposed by the FDA for nicotine laced liquid products. Their report ... cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as many ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley skin doctor ... a limited time only, patients can get the complete treatment process with a 10 ... prefer a non-invasive treatment and have loose or sagging skin. , As the ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
Breaking Medicine News(10 mins):Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3
... Postgraduate Services® (PPS®), renowned for its award-winning healthcare websites, ... and pediatric influenza, Preventing and Managing RSV Disease and ... PediatricRespiratory.org. , ... ...
... TodayMD to Deliver Comprehensive SEM Program to Medical and Dental ... ... September 9, 2009-- http://www.TodayMD.com [TodayMD], an innovator in ... announced today a strategic relationship with Google to become an ...
... Medical Solutions, Inc., a traveling healthcare staffing company, is ... 500 list of the fastest-growing private companies in the ... Solutions ranked No. 472 overall. When compared to other ... 4 and was No. 1 for all traveling healthcare ...
... over 60 million Americans diagnosed with prediabetes, putting them ... obesity-related ailments, finding ways to help large populations avoid ... published in the October 2008 issue of the ... Indiana University School of Medicine report that organizations such ...
... OF PRUSSIA, Pa., Sept. 8 Universal,Health Services, ... it has signed a,definitive agreement to sell Central ... located in Lansdale, Pennsylvania to Abington Memorial,Hospital. The ... we,expect the closing to occur later this fall., ...
... for ,08, ,09, ,10, Dey expected to ... Sept. 8 Following the completion,of a comprehensive review ... MYL ) branded specialty pharmaceutical subsidiary, Mylan,announced today that ... the company said it is reaffirming its adjusted diluted,EPS ...
Cached Medicine News:Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 3Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 4Health News:TodayMD Becomes a Google AdWords Authorized Reseller 2Health News:TodayMD Becomes a Google AdWords Authorized Reseller 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 2Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 4Health News:Community-based diabetes prevention program shows promise 2Health News:Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals 2Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 2Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 3Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 4
(Date:7/29/2015)... SOUTH SAN FRANCISCO , July 29, 2015 /PRNewswire/ ... a monoclonal antibody company focused on developing innovative therapies ... with a focus on oncology, announced today that the ... company,s investigational new drug (IND) application for KB003, an ... leukemia (CMML), and that the IND is now active. ...
(Date:7/29/2015)... N.J. , July 29, 2015  Ortho-Clinical Diagnostics, ... five assays under development. The assays address a range ... kidney injury and cardiac troponin I. The scientific posters ... Clinical Chemistry Annual Meeting to be held July 26 ...   "Ortho Clinical Diagnostics is emerging stronger ...
(Date:7/29/2015)... July 27, 2015 Research and Markets ... the "Global Neurostimulation Devices Market 2015" ... forecast the global neurostimulation devices market to grow ... 2014-2019. The report, Global Neurostimulation Devices ... in-depth market analysis with inputs from industry experts. ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2
... at Endocrine Society 90th Annual Meeting -, ... Inc. (Nasdaq: BNVI ) today announced results ... candidate, MF101. The data were presented at the,Endocrine ... neurons,differentiated from mouse stem cells and expressing native ...
... DUBLIN, Calif., June 16 SuperGen Inc.,(Nasdaq: ... to the discovery, rapid,development and commercialization of ... announced at the 13th Congress of the,European ... its JAK2 kinase inhibitor, prevents tumor cell ...
Cached Medicine Technology:Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 2Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 3SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... The AVOXimeter 4000 provides a fast, ... bedside. The AVOXimeters patented,state-of-the-art optics yield ... as well as total hemoglobin. When,used ... analyzer, the AVOXimeter,4000 gives a comprehensive ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: